Efficacy and Safety of Suprachoroidal Triamcinolone Acetonide in Cases of Resistant Diabetic Macular Edema

Background and Aim: Patients with diabetes are at risk of losing their vision due to diabetic macular edema (DME). Symptoms occur as fluid leaks from retinal vessels into the surrounding neural retina hypoglycemia-induced damage blood-retina barrier. The current study aimed assess safety efficacy suprachoroidal triamcinolone acetonide in resistant cases. Methods: This interventional case series was carried out on 32 cases Department Ophthalmology, Hayatabad Medical Complex, Peshawar during period April 2019 September 2019. All patients above 16 years age Type-1 DM or Type-2 were enrolled this study. Intraocular Pressure (IOP), Baseline Best Corrected Visual Acuity (BCVA), Central Subfield Thickness (CST) determined recorded. Post-SCTA follow-up done one three months. During follow-up, measured clinical factors noted analyzed SPSS version 26. Results: Of total cases, 15 (46.9%) male 17 (53.1%) females. overall mean 48.64 ± 8.72 years. frequency prior injections received 6.2 maximum 12 minimum four. CST pre-injection value 612.8 198.3 um post-injection months 308.6± 62.6 302.72± 58.64 respectively. Statistical significance found pre post one-month injections. BCVA 0.8 0.19 0.49 0.29 0.39 0.20 At injection, there statistical for both injection CST. A IOP 12.32 mmHg recorded pre-injection. Previously, 14.82 14.48 intraocular pressure respectively after injection. Conclusion: present that Triamcinolone Acetonide (TA) administered anatomical functional improvement. OCT thickness can be improved refractory reduced using SCT. Keywords: Resistant edema, Efficacy, Suprachoroidal